Truqap is usually a kinase inhibitor that actually works by blocking pathways that aid the cancer cells survive and expand, so lowers cancer growth. Truqap is from a class of medicines called an AKT inhibitor. Truqap obtained FDA acceptance on November 17, 2023, soon after beneficial effects from your CAPItello-291 https://sotorasib79023.theideasblog.com/35255557/5-easy-facts-about-enzalutamide-described